Lantern Pharma Inc. Loans Payable, Noncurrent
Lantern Pharma Inc. (LTRN) had Loans Payable, Noncurrent of $108.50 thousand as of 2020-06-30, per its 10-Q filed 2020-07-30.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermLoansPayable · last filed 2020-07-30
- 2020-06-30: Loans Payable, Noncurrent $108.50K.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2020-06-30 | $108.50K 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |